The aetiology of Crohn's disease and ulcerative colitis remains uncertain. Phagocytic cells are prominent in the inflamed bowel wall in both conditions.' Since the work of Metchnikoff,2 neutrophils and macrophages have been implicated in the pathogenesis of tissue damage at inflammatory sites. These cells are able to generate highly reactive metabolites of oxygen such as hydrogen peroxide (H202) and hypochlorite (OC 1-) as well as the superoxide (O2) and hydroxyl radicals (OH').34 Although these products of oxygen are involved in bacterial killing, their production outside the cell may also cause tissue damage.I One feature of Crohn's disease is the typical non-caseating granuloma 6 Parallels have been drawn between Crohn's disease and chronic granulomatous disease, where granulomas similar to those seen in Crohn's disease have been described in the rectum and the terminal ileum of symptomatic patients. 7 The oxidative capacity of circulating phagocytic cells from patients with chronic granulomatous disease is defective, these cells being unable to produce toxic oxygen metabolites when stimulated.8 This has led to speculation that phagocyte function in inflammatory bowel disease is in some way defective. 9 Neutrophils and macrophages migrating into the tissues originate from the circulating pool of neutrophils and monocytes. Therefore, any generalised defect in phagocytic function should be present in the circulating cells.
In this paper, the oxidative capacity of circulating neutrophils and monocytes has been assessed by a sensitive chemiluminescent technique to investigate the possibility that the oxidative capacity of these cells may be defective in inflammatory bowel disease.
Methods

PATIENTS
The diagnosis of Crohn's disease and ulcerative colitis was based on accepted clinical, radiological, endoscopic, and histological criteria. The median chemiluminescent response of both neutrophils and monocytes from each subject to phagocytic stimulation with latex beads is shown in Figure 3 . Figure 3 . There was no significant differences between the responses of neutrophils from controls and patients with inflammatory bowel disease (median responses; controls, 7014 cps; Crohn's disease 6194 cps and ulcerative colitis 8234 cps).
1-
The response of monocytes from patients with inflammatory bowel disease was significantly greater than control responses. Control median 280 cps, Crohn's disease 1883 cps (pO<0-0005), ulcerative colitis 1060 cps (p<0-05).
EFFECT OF DISEASE ACTIVITY ON CHEMILUMINESCENT RESPONSE
There was no difference in the response of neutrophils from patients with inactive disease compared to the response of neutrophils from patients with active disease for any of the three stimuli used (Figs 2-4) . Similarly, drug therapy did not appear to influence the magnitude of the chemiluminescent response of neutrophils or monocytes.
The chemiluminescent response of monocytes from patients with active Crohn's disease however was significantly greater than the response of patients with inactive disease after stimulation with fMLP (inactive median response 207 cps, active 526 cps, p<0-02) and after stimulation with phorbol myristate acetate (inactive 535 cps, active 2419 cps, p<0-05). The difference in response after stimulation with latex beads was not statisically significant (inactive 591 cps, active 1942 cps). For each stimulus there was no significant difference in the magnitude of the group.bmj.com on June 24, 2017 -Published by http://gut.bmj.com/ Downloaded from latex beads or phorbol myristate acetate. The response to fMLP was slightly depressed in both Crohn's disease and ulcerative colitis. Although this was statistically significant, there was considerable overlap between the three groups. Thus, it would appear that a generalised defect of toxic oxygen metabolite production by neutrophils is not present in either Crohn's disease or ulcerative colitis. Depressed chemotaxis of neutrophils in vitro in inflammatory bowel disease has been previously reported' I 2 and depressed toxic oxygen metabolite production therefore may be secondary to a defective neutrophil response to chemotactic stimulation.
Increased chemiluminescence in response to zymosan has been reported2' although the numbers studied were small and included patients with both Crohn's disease and ulcerative colitis as one group. Other studies, however, have reported no difference in the levels of luminol dependent chemiluminescence between controls and patients with Crohn's disease after stimulation with opsonised zymosan'4 and phorbol myristate acetate.
Diminished production of hydrogen peroxide by neutrophils from patients with untreated Crohn's disease has been reported," with normal production of hydrogen peroxide by neutrophils from patients with ulcerative colitis and Crohn's disease on medical treatment."'7 Superoxide production has also been reported to be significantly depressed in ulcerative colitis27' and Crohn's disease 2 in some studies, whereas in others the depression of superoxide production by neutrophils in Crohn's disease was only slight.26 27 Interpreting these findings is difficult. As hydrogen peroxide is produced by reduction of superoxide,3 a marked diminution in superoxide production would be expected to be associated with similar depression of hydrogen peroxide production.
In vivo, neutrophil activation results in the production of a series of interrelated toxic metabolites of oxygen, coupled with the release of granular enzymes29 and formation of highly reactive metabolites such as hypochlorite.5 The generation of luminol dependent chemiluminescence by phagocytic cells requires both the production of oxygen metabolites and enzyme release and probably reflects hypochlorite ion generation.30 " This method of measuring toxic oxygen metabolite production in vitro, therefore, more accurately reflects events in vivo.
Toxic oxygen metabolite production by circulating monocytes has received less attention in inflammatory bowel disease than neutrophils. This is surprising in view of the relationship between monocytes and tissue macrophages. In this study, we have shown that toxic oxygen metabolite production by circulating monocytes is significantly greater in both Crohn's disease and ulcerative colitis compared with normal controls. Furthermore, this enhanced production of oxygen metabolites was confined to monocytes from patients with active inflammatory bowel disease. Increased chemiluminescence was seen in response to each of the three different stimuli used, suggesting a generalised increased oxidative potential of these cells. Two other studies have shown increased luminol dependent chemiluminescence by circulating monocytes in Crohn's disease 42s but in neither study was a relationship to disease activity shown.
In mice, activation of the mononuclear phagocyte system by C parvum, vaccinia or murine cytomegalo virus was associated with enhanced chemiluminescence by stimulated peritoneal macrophages.'2 Similarly, increased superoxide and hydrogen peroxide production by macrophages activated in vivo and in vitro has been reported."-"
The results presented here suggest that circulating monocytes in patients with inflammatory bowel disease are 'activated'. This is supported by studies relating to other monocyte functions in inflammatory bowel disease including; -increased phagocytosis of C albicans and S azureas,4" 6I increased lysosomal hydrolase content,"-9' increased enzyme release,""' increased random motility and chemotaxis42 and increased IgG and C3b receptor activity.44 Similar 'activation' of circulating monocytes has been shown in other chronic inflammatory conditions such as rheumatoid arthritis.4" Therefore a generalised defect in toxic oxygen metabolite production by phagocytic cells is unlikely to be involved in the aetiology of inflammatory bowel disease. The response of the two types of circulating phagocytes studied, however, differed in inflammatory bowel disease. Neutrophils appeared to be functioning normally, whereas monocytes produced an enhanced response when stimulated. It is of interest that pulmonary mononuclear phagocytic cells also have enhanced oxidative metabolism."4 Further study is required to define the precise role of phagocytic cells in the aetiology of inflammatory bowel disease, especially of phagocytes at the site of inflammation in the bowel wall. 
